Drug · DIN 02455102
TALTZ
SINGLE-DOSE PREFILLED AUTO-INJECTOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 20, 2023; first marketed August 11, 2016.
- Drug Identification Number (DIN)
- 02455102
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Ixekizumab L04AC13
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IXEKIZUMAB | 80 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 25, 2016: NOC 18129New Drug Submission (NDS)
Other DINs named TALTZ
- DIN 02455110 · Marketed